• KOL
    • KOLs Community
    • Adipose
    • Adipose Tissue
    • Xavier Escoté
    • Xavier Escoté

      Xavier Escoté

      Unitat de Nutrició i Salut, Centre Tecnològic de Catalunya, Eurecat, 43204 Reus, Spain;, sergio.quesada@eurecat.org, (S.Q.-V.);, xavier.escote@eurecat.org, (X.E.) | Eurecat, ...

       

       

      KOL Resume for Xavier Escoté

      Year
      2022

      Unitat de Nutrició i Salut, Centre Tecnològic de Catalunya, Eurecat, 43204 Reus, Spain;, (S.Q.-V.);, (X.E.)

      Eurecat, Centre Tecnològic de Catalunya, Nutrition and Health Unit, 43204 Reus, Spain;,

      2021

      Eurecat, Technology Centre of Catalunya, Nutrition and Health Unit, 43204 Reus, Spain;, (S.Q.-V.);, (J.M.D.B.)

      Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, Campus Sescelades, 43007 Tarragona, Spain

      2020

      Eurecat, Centre Tecnològic de Catalunya, Unitat de Nutrició i Salut, 43204 Reus, Spain;, (J.H.-B.);, (S.Q.-V.);, (R.M.-C.);, (K.G.C.);, (A.C.);, (J.M.D.B.)

      University of Navarra, Center for Nutrition Research, School of Pharmacy and Nutrition, Pamplona, Spain

      2019

      Nutrition Research Centre, University of Navarra, Pamplona, Spain

      2018

      Food Science and Physiology

      Centre for Nutrition Research, University of Navarra, Pamplona, Spain

      Department of Nutrition

      2017

      CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)-Instituto de Salud Carlos III, Madrid, Spain

      2016

      Centre for Nutrition Research, University of Navarra Pamplona Spain

      2015

      Endocrinology and Diabetes Unit, Joan XXIII University Hospital, Institut d'Investigació Sanitària Pere i Virgili, Universitat Rovira i Virgili, Tarragona, Spain; Institut de Biomedicina de la Universitat de Barcelona de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain;

      Hospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain

      Department of Physiology, Université de Lausanne, Lausanne, Switzerland.

      2014

      Department of Physiology, Université de Lausanne, Lausanne, Switzerland

      Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain

      2013

      CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Tarragona, Spain

      2012

      CIBER Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), Tarragona, Spain

      2011

      CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM); Instituto de Salud Carlos III, Spain

      2010

      CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Spain

      Endocrinology and Diabetes Unit, Hospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili;

      Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabólicas Asociadas;

      2009

      CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Endocrinology and Diabetes Research Department, University Hospital Joan XXIII from Tarragona, School of Medicine, Rovira i Virgili University, Pere Virgili Institute, Tarragona, Spain

      2006

      Cell Signaling Unit, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF) Barcelona Spain

      2004

      Cell Signaling Unit, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), E-08003, Barcelona, Spain

       

       

      Xavier Escoté: Influence Statistics

      Sample of concepts for which Xavier Escoté is among the top experts in the world.
      Concept World rank
      waist circumference comorbidity #1
      biomarkers nmr approaches #1
      ulcerative colitic mice #1
      carrier proteins comorbidity #1
      lipolytic adipokine #1
      potential clinical treatment #1
      zag metabolic phenotypic #1
      predisease stages #1
      hypercortisolism zag levels #1
      zag metabolic #1
      hypercortisolism carrier proteins #1
      adipose tissue hypercortisolism #1
      vivo rct1 administration #1
      carbohydrate dysfunction #1
      prietovicente #1
      correlated hypercortisolism #1
      metabolic phenotypic zag #1
      zag secretion #1
      zag glucocorticoids #1
      lower colon damage #1
      zag expression sat #2
      zag maternal serum #2
      cbzag gestational age #2
      ω3 lcpufas role #2
      metabolic cofactors #2
      cbzag #2
      offspring cord blood #2
      disturbed secretory pattern #2
      epa cognitive function #2
      ω3 lcpufas dha #2
      serum zag concentration #2
      animals nafld #2
      hog1 cell survival #2
      maternal serum cbzag #2
      zincα2glycoprotein gestational diabetes #2
      proinflammatory factors production #2
      adipokine lipolytic #2
      structured forms epa #2
      cord blood zag #2
      maternal zag #2
      zag maternal #2

       

      Prominent publications by Xavier Escoté

      KOL-Index: 11869

      CONTEXT: Zinc-alpha2-glycoprotein (ZAG) is a soluble protein similar to the class I major histocompatibility complex heavy chain, which has been implicated in lipid catabolism. We hypothesized that ZAG mRNA expression in adipose tissue may be linked with lipolytic and adipokine gene expression and have a close relationship with clinical phenotype.

      OBJECTIVES: The objective of the study was to analyze ZAG gene expression in human adipose tissue from lean and obese subjects. ZAG ...

      Known for Adipose Tissue | Gene Expression | Zag Sat | Insulin Resistance | Plasma Levels
      KOL-Index: 11585

      OBJECTIVE: Zinc-α(2) glycoprotein (ZAG) stimulates lipid loss by adipocytes and may be involved in the regulation of adipose tissue metabolism. However, to date no studies have been made in the most extreme of obesity. The aims of this study are to analyze ZAG expression levels in adipose tissue from morbidly obese patients, and their relationship with lipogenic and lipolytic genes and with insulin resistance (IR).

      METHODS: mRNA expression levels of PPARγ, IRS-1, IRS-2, lipogenic and ...

      Known for Insulin Resistance | Adipose Tissue | Morbidly Obese | Gene Expression | Sat Vat
      KOL-Index: 11244

      OBJECTIVES: A relationship between obesity and intestinal bacterial translocation has been reported. Very little information is available with respect to the involvement of the bacterial translocation mechanistic pathway in HIV-1/highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome (HALS). We determined whether lipopolysaccharide (LPS)-binding protein (LBP), cluster of differentiation 14 (CD14), myeloid differentiation protein 2 (MD2) and toll-like receptor 4 ...

      Known for Lipodystrophy Syndrome | Plasma Levels | Patients Hals | Antiretroviral Therapy | Receptor 4
      KOL-Index: 10947

      BACKGROUND: Little information is available with respect to the involvement of resistin in lipodystrophy and metabolic disturbances in HIV-1-infected patients treated with combination antiretroviral therapy (cART). We determined whether the resistin (rest) -420C>G single-nucleotide polymorphism and plasma resistin are associated with the development of lipodystrophy and metabolic disturbances in HIV-1-infected patients treated with cART.

      METHODS: The study group comprised 299 ...

      Known for Insulin Resistance | Infected Patients | Combination Antiretroviral | Resistin Levels | Treated Hiv1
      KOL-Index: 10853

      The beneficial actions of n-3 fatty acids on obesity-induced insulin resistance and inflammation have been related to the synthesis of specialized proresolving lipid mediators (SPMs) like resolvins. The aim of this study was to evaluate the ability of one of these SPMs, maresin 1 (MaR1), to reverse adipose tissue inflammation and/or insulin resistance in two models of obesity: diet-induced obese (DIO) mice and genetic (ob/ob) obese mice. In DIO mice, MaR1 (2 μg/kg; 10 d) reduced ...

      Known for Maresin 1 | Adipose Tissue | Insulin Sensitivity | Obese Mice | Akt Phosphorylation
      KOL-Index: 10488

      Activation of stress-activated protein kinases (SAPKs) is essential for proper cell adaptation to extracellular stimuli. The exposure of yeast cells to high osmolarity, or mutations that lead to activation of the Hog1 SAPK, result in cell-cycle arrest1,2,3,4. The mechanisms by which Hog1 and SAPKs in general regulate cell-cycle progression are not completely understood5,6,7,8. Here we show that Hog1 regulates cell cycle progression at the G1 phase by a dual mechanism that involves ...

      Known for G1 Phase | Cycle Arrest | Cyclin Expression | Cerevisiae Saccharomyces | Yeast Cells
      KOL-Index: 10280

      Lipid overload in obesity and type 2 diabetes is associated with adipocyte dysfunction, inflammation, macrophage infiltration, and decreased fatty acid oxidation (FAO). Here, we report that the expression of carnitine palmitoyltransferase 1A (CPT1A), the rate-limiting enzyme in mitochondrial FAO, is higher in human adipose tissue macrophages than in adipocytes and that it is differentially expressed in visceral vs. subcutaneous adipose tissue in both an obese and a type 2 diabetes ...

      Known for Adipocytes Macrophages | Fatty Acid Oxidation | 2 Diabetes | Enhanced Fao | Insulin Sensitivity
      KOL-Index: 10111

      Adipose tissue releases bioactive mediators called adipokines. This review focuses on the effects of omentin, vaspin, cardiotrophin-1, Tumor necrosis factor-like Weak Inducer of Apoptosis (TWEAK) and nephroblastoma overexpressed (NOV/CCN3) on obesity and diabetes. Omentin is produced by the stromal-vascular fraction of visceral adipose tissue. Obesity reduces omentin serum concentrations and adipose tissue secretion in adults and adolescents. This adipokine regulates insulin sensitivity, ...

      Known for Omentin Vaspin | Nov Ccn3 | Adipose Tissue | Obese Subjects | Obesity Tweak
      KOL-Index: 9748

      Control of cell cycle progression by stress-activated protein kinases (SAPKs) is essential for cell adaptation to extracellular stimuli. Exposure of yeast to osmostress leads to activation of the Hog1 SAPK, which controls cell cycle at G1 by the targeting of Sic1. Here, we show that survival to osmostress also requires regulation of G2 progression. Activated Hog1 interacts and directly phosphorylates a residue within the Hsl7-docking site of the Hsl1 checkpoint kinase, which results in ...

      Known for G2 Arrest | Cell Survival | Protein Kinases | Hog1 Activation | Saccharomyces Cerevisiae
      KOL-Index: 9408

      Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common liver disease in the world. NAFLD is principally characterized by an excessive fat accumulation in the hepatocytes. Diet is considered as one of the main drivers to modulate the composition of gut microbiota, which participate in different processes, affecting human metabolism. A disruption in the homeostasis of gut microbiota may lead to dysbiosis, which is commonly reflected by a reduction of the beneficial species and an ...

      Known for Gut Microbiota | Liver Disease | Alcoholic Fatty | Nafld Progression | Insulin Resistance
      KOL-Index: 9314

      Leptin, adiponectin and IL18 are adipokines related with obesity, insulin resistance and dyslipidemia in the general population. Treated HIV-1-infected patients with lipodystrophy may develop insulin resistance and proatherogenic dyslipidemia. We assessed the relationship between plasma adipokine levels, adipokine genetics, lipodystrophy and metabolic disturbances. Plasma leptin, adiponectin and IL18 levels were assessed in 446 individuals: 282 HIV-1-infected patients treated with ...

      Known for Insulin Resistance | Infected Patients | Adiponectin Levels | Presence Lipodystrophy | Hiv Infections
      KOL-Index: 9251

      BACKGROUND: FABP4 is predominantly expressed in adipose tissue, and its circulating levels are linked with obesity and a poor atherogenic profile.

      OBJECTIVE: In patients with a wide BMI range, we analyze FABP4 expression in adipose and hepatic tissues in the settings of obesity and insulin resistance. Associations between FABP4 expression in adipose tissue and the FABP4 plasma level as well as the main adipogenic and lipolytic genes expressed in adipose tissue were also ...

      Known for Adipose Tissue | Fabp4 Expression | Protein Levels | Insulin Resistance | Fatty Acid
      KOL-Index: 9165

      The increase in glucagon-like peptide-1 (GLP-1) activity has emerged as a useful therapeutic tool for the treatment of type 2 diabetes mellitus. The actions of GLP-1 on β-cells and the nervous and digestive systems are well known. The action of this peptide in adipose tissue (AT), however, is still poorly defined. Furthermore, no relationship has been established between GLP-1 receptor (GLP-1R) in AT and obesity and insulin resistance (IR). We provide evidence for the presence of this ...

      Known for Insulin Resistance | Adipose Tissue | Glp1 Receptor | Obese Subjects | 3t3 L1
      KOL-Index: 9085

      G1 cyclins, in association with a cyclin-dependent kinase (CDK), are universal activators of the transcriptional G1-S machinery during entry into the cell cycle. Regulation of cyclin degradation is crucial for coordinating progression through the cell cycle, but the mechanisms that modulate cyclin stability to control cell cycle entry are still unknown. Here, we show that a lack of phosphate downregulates Cln3 cyclin and leads to G1 arrest in Saccharomyces cerevisiae. The stability of ...

      Known for Cell Cycle | G1 Cyclin | Dependent Kinase | Saccharomyces Cerevisiae | Pho85 Phosphate
      KOL-Index: 8221

      CONTEXT: AQP7 is considered to be the sole adipose glycerol channel, and its regulation is crucial for glycemia control.

      OBJECTIVES: In this work, we aimed to further characterize AQP7 in human adipose tissue in obesity and type 2 diabetes (T2D): 1) to assess AQP7 expression levels in paired abdominal adipose tissue depots (sc and visceral); 2) to relate it with gene expression of genes involved in lipid metabolism; and 3) to confirm that AQP7 is mainly expressed in the ...

      Known for Adipose Tissue | 2 Diabetes | Gene Expression | Human Obesity | Lipid Metabolism

      Key People For Adipose Tissue

      Top KOLs in the world
      #1
      Bruce M Spiegelman
      adipose tissue insulin resistance gene expression
      #2
      Philipp E Scherer
      adipose tissue insulin resistance metabolic syndrome
      #3
      Peter Arner
      adipose tissue insulin resistance fat cells
      #4
      Gökhan Siddik Hotamisligil
      insulin resistance tumor necrosis factor adipose tissue
      #5
      Jeffrey S Flier
      insulin resistance adipose tissue leptin levels
      #6
      Saverio Cinti
      adipose tissue brown adipocytes insulin resistance

      Xavier Escoté:Expert Impact

      Concepts for whichXavier Escotéhas direct influence:Adipose tissue,  Insulin resistance,  Insulin sensitivity,  Infected patients,  Cyclin g2,  Cell cycle,  Metabolic syndrome,  Maresin 1.

      Xavier Escoté:KOL impact

      Concepts related to the work of other authors for whichfor which Xavier Escoté has influence:Adipose tissue,  Insulin resistance,  Cell cycle,  Lipid metabolism,  Type 2 diabetes,  Saccharomyces cerevisiae,  Bariatric surgery.


       

      Tools

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


      Unitat de Nutrició i Salut, Centre Tecnològic de Catalunya, Eurecat, 43204 Reus, Spain;, sergio.quesada@eurecat.org, (S.Q.-V.);, xavier.escote@eurecat.org, (X.E.) | Eurecat, Centre Tecnològic de Catalunya, Nutrition and Health Unit, 43204 Reus, Spain

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.